The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety

Authors :: Lipson, D. A.
Criner, G.
Dransfield, M. T.
Halpin, D. M. G.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lange, P.
Lomas, D. A.
Martinez, F. J.
Pascoe, S.
Singh, D.
Wise, R. A.
Lipson, D. A.
Criner, G.
Dransfield, M. T.
Halpin, D. M. G.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lange, P.
Lomas, D. A.
Martinez, F. J.
Pascoe, S.
Singh, D.
Wise, R. A.
Source :: Lipson , D A , Criner , G , Dransfield , M T , Halpin , D M G , Han , M K , Jones , C E , Kilbride , S , Lange , P , Lomas , D A , Martinez , F J , Pascoe , S , Singh , D & Wise , R A 2019 , ' The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety ' , American Journal of Respiratory and Critical Care Medicine , vol. 199 , no. A3334 , B45 . <
Publication Year :: 2019

Database :: OAIster
Journal :: Lipson , D A , Criner , G , Dransfield , M T , Halpin , D M G , Han , M K , Jones , C E , Kilbride , S , Lange , P , Lomas , D A , Martinez , F J , Pascoe , S , Singh , D & Wise , R A 2019 , ' The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety ' , American Journal of Respiratory and Critical Care Medicine , vol. 199 , no. A3334 , B45 . <
Notes :: English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1322725987
Document Type :: Electronic Resource

Tools